Meta-Analysis: Parenting Children and Adolescents With Attention-Deficit/Hyperactivity Disorder Compared to Healthy Controls.

J Am Acad Child Adolesc PsychiatryDec 30, 2025 (epub)
Clinical ResearchPsychiatryPediatrics

Tudor Văidean, Anca Dobrean, Elena Predescu et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis compared parenting practices in families of children and adolescents (≤18 years) with specialist-confirmed ADHD and non-clinical controls. It included 62 studies from 19 countries, with 13,105 participants. Compared with controls, parents of children with ADHD showed lower positive parenting (Hedges g = -0.37, 95% CI = -0.46 to -0.27) and higher negative parenting (g = 0.47, 95% CI = 0.39 to 0.56). The authors reported high heterogeneity and noted that cross-sectional designs limit causal inference.

Key findings

  • Positive parenting was lower in ADHD families than controls (g = -0.37, 95% CI = -0.46 to -0.27).
  • Negative parenting was higher in ADHD families than controls (g = 0.47, 95% CI = 0.39 to 0.56).
  • The strongest reported differences included abuse (g = 0.60), authoritative parenting (g = -0.56), family conflict (g = 0.52), and hostility (g = 0.51).
  • Heterogeneity was high (I 2 ≥ 90%), with no consistent moderators or small-study effects identified.

Why it matters

The findings indicate that parenting practices differ between families of children with ADHD and non-clinical controls, including in warmth, conflict, and harsh discipline. These patterns are relevant to understanding family context and support needs, but the evidence does not establish whether parenting differences contribute to ADHD or arise in response to it.

What to keep in mind

High heterogeneity across studies and cross-sectional designs limit interpretation and causal inference.

Source

Published in J Am Acad Child Adolesc Psychiatry. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.